A study revealed that activating sensory nerves in breast tumors aids cancer growth and spread. Researchers found that using an FDA-approved anti-nausea drug, aprepitant, can disrupt this pathway, potentially halting breast cancer progression in mice and suggesting new treatment possibilities for humans.